ArticleScientific reports2026
Improving ofloxacin removal and antifouling performances of polysulfone-based mixed matrix membranes using chitosan-grafted UiO-66-NH
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Polymeric membranes are widely used these days for wastewater treatment applications; however, in pressure-driven filtration processes, their intrinsic hydrophobicity often leads to severe fouling and reduced separation efficiency. In this study, a novel chitosan (CTS)-grafted metal-organic framework (UiO-66-CTS MOF) was synthesized and used as a stable filler in a polysulfone (PSF) matrix to enhance the hydrophilicity of resulting mixed matrix membranes (MMMs) and prevent nanoparticle agglomeration. CTS was grafted onto UiO-66-NH2 via a Schiff-base reaction, utilizing glutaraldehyde (GA) as a linker due to the presence of amino groups in both components. The successful synthesis of MOFs was confirmed by various characterization techniques, with the results demonstrating their effective formation. Separation performances of the prepared membranes were evaluated by pure water flux, pollutant rejection, and antifouling properties. Results revealed that UC-1.25 (containing 1.25% UiO-66-CTS) exhibited the best performance in the evaluation compared with pure PSF and U-1 (containing 1% UiO-66-NH2) membranes. UC-1.25 showed a significantly enhanced pure water flux of 2.92 L/m2.h, compared to 0.39 L/m2.h for the pristine PSF and 2.27 L/m2.h for U-1. In terms of pollutant rejection, UC-1.25 achieved 94.95% rejection of ofloxacin (OFL) antibiotics, outperforming PSF (71.33%) and U-1 (91.99%). Furthermore, UC-1.25 demonstrated improved antifouling behavior, with a flux recovery ratio (FRR) of 95.14%, whereas PSF and U-1 exhibited FRRs of 61.72% and 91.74%, respectively. These findings confirm that grafting CTS onto the UiO-66-NH2 MOFs effectively enhances the membrane’s hydrophilicity and separation performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.